Previous Article | Next Article ![]()
Infection and Immunity, September 1999, p. 4326-4333, Vol. 67, No. 9
Wyeth-Lederle Vaccines, West Henrietta, New
York 14586-9728,1 and Institute for the
Study of Human Bacterial Pathogenesis, Department of Pathology, Baylor
College of Medicine, Houston, Texas 770302
Received 9 February 1999/Returned for modification 14 April
1999/Accepted 8 June 1999
The extracellular cysteine protease from Streptococcus
pyogenes is a virulence factor that plays a significant role in
host-pathogen interaction. Streptococcal protease is expressed as an
inactive 40-kDa precursor that is autocatalytically converted into a
28-kDa mature (active) enzyme. Replacement of the single cysteine
residue involved in formation of the enzyme active site with serine
(C192S mutation) abolished detectable proteolytic activity and
eliminated autocatalytic processing of zymogen to the mature form. In
the present study, we investigated activity of the wild-type (wt) streptococcal protease toward human fibrinogen and bovine casein. The
former is involved in blood coagulation, wound healing, and other
aspects of hemostasis. Treatment with streptococcal protease resulted
in degradation of the COOH-terminal region of fibrinogen
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Fibrinogen Cleavage by the Streptococcus
pyogenes Extracellular Cysteine Protease and Generation of
Antibodies That Inhibit Enzyme Proteolytic Activity
chain,
indicating that fibrinogen may serve as an important substrate for this
enzyme during the course of human infection. Polyclonal antibodies
generated against recombinant 40- and 28-kDa (r40- and r28-kDa) forms
of the C192S streptococcal protease mutant exhibited high enzyme-linked
immunosorbent assay titers but demonstrated different inhibition
activities toward proteolytic action of the wt enzyme. Activity of the
wt protease was readily inhibited when the reaction was carried out in
the presence of antibodies generated against r28-kDa C192S mutant.
Antibodies produced against r40-kDa C192S mutant had no significant
effect on proteolysis. These data suggest that the presence of the
NH2-terminal prosegment prevents generation of functionally
active antibodies and indicate that inhibition activity of antibodies
most likely depends on their ability to bind the active-site region
epitope(s) of the protein.
*
Corresponding author. Mailing address: Department of
Protein and Analytical Chemistry, Wyeth-Lederle Vaccines, 211 Bailey Rd., West Henrietta, NY 14586-9728. Phone: (716) 273-7565. Fax: (716)
273-7515. E-mail: matsukay{at}war.wyeth.com.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»